Re: Endpoints for Clinical Trials in Primary Hyperoxaluria.
Publication
, Journal Article
Assimos, DG
Published in: J Urol
September 2020
Duke Scholars
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
September 2020
Volume
204
Issue
3
Start / End Page
613
Location
United States
Related Subject Headings
- Urology & Nephrology
- Hyperoxaluria, Primary
- Hyperoxaluria
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Assimos, D. G. (2020). Re: Endpoints for Clinical Trials in Primary Hyperoxaluria. J Urol, 204(3), 613. https://doi.org/10.1097/JU.0000000000001173.02
Assimos, Dean G. “Re: Endpoints for Clinical Trials in Primary Hyperoxaluria.” J Urol 204, no. 3 (September 2020): 613. https://doi.org/10.1097/JU.0000000000001173.02.
Assimos DG. Re: Endpoints for Clinical Trials in Primary Hyperoxaluria. J Urol. 2020 Sep;204(3):613.
Assimos, Dean G. “Re: Endpoints for Clinical Trials in Primary Hyperoxaluria.” J Urol, vol. 204, no. 3, Sept. 2020, p. 613. Pubmed, doi:10.1097/JU.0000000000001173.02.
Assimos DG. Re: Endpoints for Clinical Trials in Primary Hyperoxaluria. J Urol. 2020 Sep;204(3):613.
Published In
J Urol
DOI
EISSN
1527-3792
Publication Date
September 2020
Volume
204
Issue
3
Start / End Page
613
Location
United States
Related Subject Headings
- Urology & Nephrology
- Hyperoxaluria, Primary
- Hyperoxaluria
- Humans
- 3202 Clinical sciences
- 1103 Clinical Sciences